Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Chart Review of Memantine Use in the Treatment of Obsessive-Compulsive Disorder at the OCD Institute

NCT00869505 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00869505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00869505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Chart Review of Memantine Use in the Treatment of Obsessive-Compulsive Disorder at the OCD Institute
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive-compulsive disorder